Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2026-02-24 @ 8:51 AM
Study NCT ID:
NCT02514551
Status:
COMPLETED
Last Update Posted:
2020-06-17
First Post:
2015-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-31
First Submit QC Date:
None
Study First Post Date:
2015-08-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-23
Results First Submit QC Date:
None
Results First Post Date:
2018-12-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-10
Last Update Post Date:
2020-06-17
Last Update Post Date Type:
ACTUAL